Parvovirus B19 is the causative agent of a variety of clinical manifestations, ranging from asymptomatic to severe infection. The basis for this complex pattern of B19-associated diseases is as yet poorly understood. In general there are two different possibilities: firstly, the infected individuals may have a genetic or acquired predisposition, which renders them susceptible for a certain course of infection; secondly, differences in the B19 genome may result in different outcomes of infection. In order to investigate this second possibility we have partially sequenced the genomes of 20 different B19 isolates derived from serum samples from patients with various B19-associated diseases. Four distinct regions, which cover nearly half of the genome and include parts of the coding regions of all three major B19 proteins-NS1, VP1 and VP2, were selected for sequencing. Comparisons between the different extracted virus isolates at the DNA and protein levels revealed that isolates from patients with persistent parvovlrus B19 infection show a tendency towards higher genome variability with respect to isolates derived from persons with acute infection.
hydrops fetalis as a consequence of transplacenta[ infection during pregnancy (Anderson et a]., 1988) . In the immunocompetent host, production of B19-specific antibodies results in clearing of the viraemia within a few days (Cohen et al., 1983) , whereas in immunocompromised patients extended viral persistence has been reported (Kurtzman et al., 1987 (Kurtzman et al., , 1989 Frickhofen et al., 1990) . This is also the case in patients with B19-associated arthritis (Foto et al., 1993) . In synovial fluids and bone marrow of patients with B19-associated arthritis, viral DNA has been detected by PCR, although the acute infection had occurred years ago. Some of these patients were seronegative for VP-specific antibodies (Saal et aI., 1992) . Recently, reports on persistent infections in obviously immunocompetent hosts have accumulated (Pont et al., 1992; Cassinotti et al., 1993; Brown et aI., 1994; Kerr eta] ., 1995) , an observation that has not been explained so far. In addition to the continuous presence of the virus, persistently infected patients often show a modified immune response in contrast to other patients, who generally show life-long immunity after B19 infection. Furthermore, antibodies against the nonstructural protein NSI have been detected in patients with B19-associated arthritis and persistent infection, but not in other patients with B19 infection (von Poblotzki et aI., I995 a, b) .
To elucidate the factors responsible for determining the course of infection, we have partially sequenced the genomes of 20 different B19 isolates extracted from serum samples from patients with various B19-associated diseases. Four distinct regions of the genome, designated NS1-C, AV, VP1/VP2 and VPC, were amplified by nested PCR and sequenced. These four regions cover nearly half of the B19 genome (see Fig. 1 ) and include genetic information from the three major viral proteins: NS1, VPI and VP2. All obtained sequences were translated into the corresponding amino acid sequences and comparisons were made at the DNA and protein levels. Based on these data it was possible to draw conclusions about the variety of different B19 strains and identify putative correlations between the DNA sequence and the outcome of infection. Serum samples were collected from patients suffering from a variety of B19-associated symptoms ( Arthritis 1"1 I"6 0'7 0"6 1'0 0'7 1"0 0 $471 Arthritis I"3 2"4 0'5 1"5 1"7 0"7 1"0 0 $724 Arthritis 1"1 1"6 0"9 1'7 1"7 0'7 1"4 2"1 $752
Arthritis 1"1 1"6 1"8 3"3 2"2 2"1 1"0 0'7 3 Arthritis 1"1 I"6 1"4 1"0 i"7 0"7 I'7 0"7 RR Arthritis ND ND ND ND 2"2 2"1 1"4 0 A Persistent infection 1"3 3"2 0"3 0 2"9 3"6 0 0 B Persistent infection 2"1 4"0 1"9 2"8 2"4 2"9 2-4 3"6 C Persistent infection 0'5 0-8 4"0 8"2 1"7 I'4 1"4 0 SP2 Persistent infection 0"8 0'8 1'0 1'1 I'4 0"7 0"7 0 4
Persistent infection 0"8 0'8 3'3 6'8 1"4 I'4 0"2 0 5
Persistent infection 1"3 I"6 1"6 2"2 I'2 0"7 1"4 0 ND, Not done.
Samples were obtained from 1991-1994 at different locations (Institut Rir Medizinische Mikrobiologie und Hygiene, Universit/it Regensburg, Germany; Institut ffir Virologie, UniversiNit Wien, Austria; Max von Pettenkofer-Institut, Mfinchen, Germany; Rheumaklinik Olsberg, Germany; H6pital Cantonal Universitaire de Gen6ve, Division de Rheumatologie, Gen6ve, Switzerland; Department of Virology, University of Helsinki, Helsinki, Finland). For PCR, serum samples were diluted 1:1 with water and incubated at 95 °C for 10 rain. After this heat treatment, aggregated proteins were removed by centrifugation at 14000 r.p.m, for 15 min and 2 lal of supematant were used for PCR. The method of serum preparation applied was especially developed and provided optimal sensitivity and allowed low volumes of serum to be used. Primers for the nested PCR reactions are given in Table 2 . All nucleotide positions refer to the published sequence of parvovirus B19 (Shade e~ al., 1986) . PCR was carried out in volumes of 50 gl with the following concentration of reagents: 0"2 gM-dNTPs (Perkin Elmer), 0"5 gM of each primer, 1 x PCR buffer for Pwo polymerase [10 mMTris-HC1, pH 8"85, 25 mM-KC1, 5 mM- ( Of each reaction 10 ~tl was electrophoresed on a 2 % agarose gel followed by ethidium bromide staining. Ten genome copies could be easily detected on an agarose gel after amplification by nested PCR (data not shown). Therefore it was ensured that even serum samples with very low virus titres, as occur in patients with persistent infection, (103/ml), could be employed in the assays. All PCR fragments were extracted and purified with the Qiagen PCR purification kit and sequenced with the second round PCR primers. Sequencing was performed with the cycle sequencing method (373A Sequencer; Applied Biosystems). Almost all isolates showed positive results in all PCR reactions applied; there were only a few exceptions which did not show positive results after all amplifications: serum MH, negative in the AV region, and serum RR, negative in the regions NSI-C and hV. As sequences were examined for point mutations it was important to exclude mutations introduced by PCR. Therefore Pwo DNA polymerase (from Pyrococcus woesei) was used in all assays, because of its proof-reading activity. Furthermore three independent PCR products from each isolate were sequenced. In all cases the primers of the second round of amplification were used for sequencing. This method was applied without difficulties except with the AV region. Part of the problem could be overcome by using a new sequencing primer, but nevertheless it was not possible to obtain complete sequence data in the VP1 unique region.
All nucleotide sequences were translated into amino acid sequences and comparisons between the different B19 isolates were made at the DNA and protein levels. For all alignments the published sequence of isolate pYTI03 (Shade et aI., 1986) was used as a standard. Therefore all nucleotide and amino acid positions refer to this sequence and differences between the 20 isolates and the reference strain pYT103 were analysed. Hence it was possible to obtain data about the variability of different B19 isolates.
In the NS1-C region 19 sera showed positive PCR results. The sequenced region contains the genome section from nt 1950-2325. Between nt 1950-2020, exchanges accumulate (22 exchanges in 70 bp), followed by a relatively conserved stretch of about 220 bp with only few alterations (nt 2020-2240; 12 exchanges). The variability of all isolates ranged from 0"5 to 2"1%, but it was noticed that the isolates from patients with arthritis and persistent infection showed a twofold higher variability (mean 1'2%) than isolates obtained from persons with acute infection (mean 0"6 %). In particular, exchanges in the variable region spanning nt 1950-2020 were preferentially found in virus isolates derived from arthritis and persistently infected patients ($453, $47I, $724, $752, A, B, C, SP2, 5). At the protein level the examined region corresponds to the carboxy-terminal domain of NS1 from amino acids (aa) 500--625. All isolates exhibited changes in their DNA sequences, nevertheless some isolates were identical to the standard pYTI03 at the protein level due to silent mutations. In analogy to the DNA data, the protein part from aa 500--530, encoded by the variable DNA domain from nt 1950-2020, showed a higher variation (aa 500-530; 19 exchanges) than the remaining part (aa 530-625 ; 10 exchanges). Although NS1 is a non-structural protein, it is under high selective pressure due to its essential enzymatic and biological properties; variability in the NS1-C region ranges from 0-4"0% at the protein level. However, changes are not equally frequent within all isolates. B19 DNA derived from patients with persistent infection and arthritis showed a higher degree of diversity (mean 1"7%) with respect to those from acutely infected patients (mean 0" 7 %). Additionally, the quality of the amino acid exchanges in these isolates is different: in a defined region of 25 residues (aa 500-524) a shift from polar (serine) towards basic amino acids (mainly arginine) was observed in isolates from persistent infection and arthritis. These changes may have great influence on protein structure and biological function. The NSI protein of parvovirus B19 has been described to be cytotoxic (Ozawa et aL, I988) ; an ATPase and helicase activity as well as promotor-binding properties have been predicted from comparisons to non-structural proteins from autonomous animal parvoviruses (Doerig et a]., 1990) . These functions may have an important influence on the course of infection. The observation that exchanges occur most frequently within the isolates of patients with persistent infection and arthritis may point to modified biological properties. Furthermore, it is known that NS1 controls its own promotor and thus autoregulates its own transcription (Doerig et al., 1990) . Mutations that influence the activation of transcription, may lead to the synthesis of different amounts of NSI protein, which may influence the course of infection due to its cytotoxic properties. Alternatively, modifications of the protein structure may alter the antigenicity and the recognition of B cell epitopes. This is particularly interesting since antibodies against NSI protein can only be detected in patients with arthritis and persistent infection (von Poblotzki et a]., 1995 a, b).
Amplification in the VP1 unique region (dlV) was positive for 18 isolates, but as sequencing was difficult to perform, only incomplete sequence data from 15 isolates were obtained. Some of the problems could be overcome by the use of an additional sequencing primer. The AV sequences comprise the genome region from nt 2240-3015 and exchanges were equally distributed over the whole analysed part. The corresponding protein sequence represents the unique region of VP1 from amino acid position 1-190. The variability of the AV region ranged from 0"3 to 4% at the DNA and from 0 to 8-2 % at the protein level. These high degrees of variability could not be found within all sequences; only two isolates, C and 4 (derived from persistently infected patients), exhibited maximum variabilities in the VP1 unique region (C, 8-2 %; 4, 6"8 %) . The other isolates showed a definitely lower diversity (0-1"7%). Furthermore, the mutations in isolates C and 4 resulted in non-conservative amino acid alterations (often unpolar, uncharged residues were replaced by polar or charged amino acids). It is known that the unique region of VP1 plays a crucial role in eliciting a neutralizing immune response (Saikawa et aI., 1993; Rosenfeld et a]., 1994) . Patients with persistent infection are often not able to eliminate the virus as they cannot produce efficient B19-neutralizing antibodies or their antibody titres are too tow (Kurtzman et at., 1989) . This failure may be due to alterations of the viral proteins, resulting in a modified viral surface, so that efficient virus elimination is not possible.
The junction region between the coding sequences of the two structural proteins (VP1/VP2) was analysed from nt 2985-3400 for all 20 isolates, which were positive in the nested PCR. In contrast to the neighbouring unique region of VPI, which was highly variable in some isolates, the region from nt 2985-3170 was highly conserved, and only a few nucleotide changes could be identified (3 in I85 bp). This conserved stretch was again followed by a section, where at defined positions exchanges occur in many isolates (nt 3170-3400; 133 exchanges). By comparing the 20 isolates to the standard, pYT103, three positions (nts 3184, 3225 and 3357) could be identified at which all analysed sequences differed from the reference strain. Therefore it may be assumed that the standard pYT103 differs from a theoretical consensus motif, which occurs in all other isolates. The overall variability ranged from I"2-1"7% in most isolates, but was higher within some isolates from patients with persistent infection (isolate A, 2"9 % and isolate B 2"4 %). The corresponding protein part spans the VPI/VP2 junction region from amino acids I80-320 (VP1 reading frame); this region is also involved in eliciting a neutralizing immune response (Yoshimoto et al., 199I) . Most nucleotide exchanges in the junction region are silent mutations, therefore the variability is much lower at the protein level. As was also seen at the DNA level, only few positions were concerned in exchanges, but at these positions differences could be found in many of the sequences examined (positions 247, 248, 259 and 299); at one position (residue 247 of VPI) all isolates differ from pYTI03. Isolates from patients with persistent infection exhibited a twofold higher variability (mean 1"8 %) than other isolates (mean 0'9%).
The region encoding the collinear carboxy-terminal domains of the two structural proteins (VPC) was amplified and the sequences of all 20 positive reactions were compared from nt 4000-4420. This region showed many nucleotide exchanges distributed over the whole section, without cluster conformation. The variability ranged from 0-2"4% at the DNA level. Most mutations however remained silent or led to conservative amino acid replacements in the corresponding protein sequence from position 520-660 (VP1 reading frame). About 50% of all isolates analysed were identical to the standard B19 strain pYTI03 at the protein level, By means of the data presented the following tendency can be observed: isolates from patients with persistent infection exhibit a higher degree of variability, both at the DNA and protein levels. This may be due to a modest continuous replication during persistence in the host, leading to an accumulation of changes. But the higher variability is not equally apparent in all regions of the B19 genome and changes are not randomly distributed. At positions where exchanges occur in many isolates, all alterations found were identical; e.g. at amino acid position 508 of the NS1 protein four isolates from persistently infected patients diverge from the standard pYTI03 and all replacements are serine to arginine in this case. This kind of exchange pattern was found in 95 % of all replacements, both at the DNA and protein levels. Thus the extent of genome variability seems to be controlled by selective pressure. Furthermore, the quality of the amino acid exchanges found in some of the analysed regions leads to the 78z speculation that viral factors are at least partly involved in determining the course and outcome of parvovirus B19 infections.
